These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
929 related items for PubMed ID: 25804925
1. Normobaric hyperoxia slows blood-brain barrier damage and expands the therapeutic time window for tissue-type plasminogen activator treatment in cerebral ischemia. Liang J, Qi Z, Liu W, Wang P, Shi W, Dong W, Ji X, Luo Y, Liu KJ. Stroke; 2015 May; 46(5):1344-1351. PubMed ID: 25804925 [Abstract] [Full Text] [Related]
2. Normobaric hyperoxia reduces the neurovascular complications associated with delayed tissue plasminogen activator treatment in a rat model of focal cerebral ischemia. Liu W, Hendren J, Qin XJ, Liu KJ. Stroke; 2009 Jul; 40(7):2526-31. PubMed ID: 19478225 [Abstract] [Full Text] [Related]
3. Normobaric Hyperoxia Reduces Blood Occludin Fragments in Rats and Patients With Acute Ischemic Stroke. Shi S, Qi Z, Ma Q, Pan R, Timmins GS, Zhao Y, Shi W, Zhang Y, Ji X, Liu KJ. Stroke; 2017 Oct; 48(10):2848-2854. PubMed ID: 28931617 [Abstract] [Full Text] [Related]
4. Pinocembrin Protects Blood-Brain Barrier Function and Expands the Therapeutic Time Window for Tissue-Type Plasminogen Activator Treatment in a Rat Thromboembolic Stroke Model. Ma Y, Li L, Kong L, Zhu Z, Zhang W, Song J, Chang J, Du G. Biomed Res Int; 2018 Oct; 2018():8943210. PubMed ID: 29850586 [Abstract] [Full Text] [Related]
9. Effects of tissue plasminogen activator on cerebral microvessels of rats during focal cerebral ischemia and reperfusion. Yang DY, Pan HC, Chen CJ, Cheng FC, Wang YC. Neurol Res; 2007 Apr; 29(3):274-82. PubMed ID: 17509227 [Abstract] [Full Text] [Related]
10. Combination therapy with normobaric oxygen (NBO) plus thrombolysis in experimental ischemic stroke. Fujiwara N, Murata Y, Arai K, Egi Y, Lu J, Wu O, Singhal AB, Lo EH. BMC Neurosci; 2009 Jul 15; 10():79. PubMed ID: 19604385 [Abstract] [Full Text] [Related]
11. Bryostatin extends tPA time window to 6 h following middle cerebral artery occlusion in aged female rats. Tan Z, Lucke-Wold BP, Logsdon AF, Turner RC, Tan C, Li X, Hongpaison J, Alkon DL, Simpkins JW, Rosen CL, Huber JD. Eur J Pharmacol; 2015 Oct 05; 764():404-412. PubMed ID: 26189021 [Abstract] [Full Text] [Related]
12. Ascorbic Acid Reduces the Adverse Effects of Delayed Administration of Tissue Plasminogen Activator in a Rat Stroke Model. Allahtavakoli M, Amin F, Esmaeeli-Nadimi A, Shamsizadeh A, Kazemi-Arababadi M, Kennedy D. Basic Clin Pharmacol Toxicol; 2015 Nov 05; 117(5):335-9. PubMed ID: 25899606 [Abstract] [Full Text] [Related]
19. Matrix metalloproteinase activation and blood-brain barrier breakdown following thrombolysis. Kelly MA, Shuaib A, Todd KG. Exp Neurol; 2006 Jul 05; 200(1):38-49. PubMed ID: 16624294 [Abstract] [Full Text] [Related]
20. Cell permeable HMGB1-binding heptamer peptide ameliorates neurovascular complications associated with thrombolytic therapy in rats with transient ischemic stroke. Li M, Chen S, Shi X, Lyu C, Zhang Y, Tan M, Wang C, Zang N, Liu X, Hu Y, Shen J, Zhou L, Gu Y. J Neuroinflammation; 2018 Aug 23; 15(1):237. PubMed ID: 30139371 [Abstract] [Full Text] [Related] Page: [Next] [New Search]